ImmunisLogoWImmunisLogoImmunis Inc. Featured by DelveInsight for Recent Developments in Knee Osteoarthritis ResearchImmunis Inc. Featured by DelveInsight for Recent Developments in Knee Osteoarthritis Research
  • Home
  • About
  • Technology
  • Clinical Trials
  • News & Media
  • Contact
✕
Immunis Chairman Dr. Hans Keirstead to Present at the 2023 Biotech Showcase
Immunis Recruits Individuals with Muscle Atrophy for Phase 1/2a Clinical Trial
Immunis Inc. Featured by DelveInsight for Recent Developments in Knee Osteoarthritis Research
IRVINE, Calif. — January 16, 2023 — Immunis Inc. was featured by DelveInsight Business Research LLP as one of six companies with recent developments in researching a treatment for knee osteoarthritis. DelveInsight is a leading Business Consultant and Market Research Firm that examines the innovative landscape of the healthcare industry to inform decision-makers on critical issues and opportunities. For more information about the article, read here.

###

Share

Recent News

  • Jan 26, 2023

    Immunis Chairman Dr. Hans Keirstead to Present at 2023 BIO CEO and Investor Conference

  • Jan 24, 2023

    Immunis Recruits Individuals with Muscle Atrophy for Phase 1/2a Clinical Trial

  • Jan 16, 2023

    Immunis Inc. Featured by DelveInsight for Recent Developments in Knee Osteoarthritis Research

Navigation

  • Home
  • About
  • Technology
  • Clinical Trials
  • News & Media
  • Contact

Contact info

Immunis, Inc.
Irvine, California


contact@immunisbiomedical.com

© 2022 Immunis, Inc. | All Rights Reserved